Management of Duchenne Muscular Dystrophy with Acute Hypercapnic Respiratory Failure
Initiate non-invasive ventilation (NIV) immediately in a critical care or respiratory support unit—do not wait for acidosis to develop, as deterioration can be rapid and sudden in DMD patients. 1
Immediate Assessment and Monitoring
Obtain arterial or capillary blood gas analysis urgently to confirm hypercapnia (>45 mm Hg/6 kPa) and assess pH, as even modest CO2 elevation signals impending crisis in neuromuscular disease. 1
Place patient in HDU/ICU or respiratory support unit due to high risk of sudden deterioration—standard ward monitoring is insufficient. 1
Contact the patient's specialist respiratory and neuromuscular teams immediately for guidance, as these patients require expert input for optimal management. 1
Assess for bulbar dysfunction (difficulty swallowing, weak cough, speech changes), as this makes NIV more difficult and increases failure risk. 1
Oxygen Therapy: Critical Caution
Avoid administering oxygen alone without ventilatory support—this is relatively contraindicated in DMD as it worsens hypercapnia. 1
If oxygen is required alongside NIV, target saturations of 88-92% in adults or >92% in children, not normalization. 1, 2
Recognize that saturations <95% indicate the patient is unwell and at high risk of deterioration, requiring urgent intervention. 1
High-flow uncontrolled oxygen should never be empirically administered. 1, 2
Non-Invasive Ventilation Protocol
Start NIV with controlled ventilation mode (pressure control ventilation) rather than pressure support, as triggering is often ineffective in neuromuscular disease. 1
Initial Ventilator Settings:
- Inspiratory pressure (IPAP): 12-20 cm H₂O (start lower at 8-12 cm H₂O in DMD due to low respiratory system impedance unless significant skeletal deformity). 1, 2
- Expiratory pressure (EPAP): 4-5 cm H₂O (higher if bulbar dysfunction present to overcome upper airway obstruction). 1, 2
- Inspiratory/expiratory time ratio: 1:1 to allow adequate inspiratory time. 1
- Backup respiratory rate: 15-25 breaths/minute appropriate for neuromuscular disease. 2
NIV Implementation:
- Maximize NIV use in first 24 hours depending on tolerance—aim for continuous or near-continuous use initially. 2
- Select appropriate mask interface and familiarize patient before securing. 1
- Hold mask in place initially, then secure with headgear once patient acclimates. 1
Airway Clearance: Essential Component
Institute aggressive physiotherapy with mechanical insufflator-exsufflator (MI-E) immediately, as secretion clearance is critical and often the cause of NIV failure in DMD. 1
- Arrange urgent assessment by physiotherapist experienced in neuromuscular airway clearance techniques. 1
- Use assisted cough techniques and MI-E regularly throughout acute illness. 1, 2
- Inability to clear secretions is a common cause of NIV failure in neuromuscular disease. 1
Reassessment and Response Criteria
Recheck arterial blood gases at 1-2 hours after NIV initiation. 1, 2
If pH and PCO₂ worsen or fail to improve after 1-2 hours on optimal NIV settings:
- Do not delay intubation—escalate to invasive mechanical ventilation promptly unless this contradicts patient wishes or is deemed inappropriate. 1
- In single-organ respiratory failure, prospects for recovery are good with invasive ventilation. 1
If modest improvement but not normalized by 4-6 hours:
- Continue NIV with close monitoring and repeat blood gases. 1
- Reassess for technical issues: mask fit, leak, ventilator settings, secretion burden. 1
Indications for Immediate Intubation
Proceed directly to invasive mechanical ventilation if: 1, 2
- Respiratory arrest or peri-arrest situation
- Inability to protect airway or manage excessive secretions despite MI-E
- Hemodynamic instability
- Patient exhaustion or decreased consciousness
- Severe bulbar dysfunction preventing effective NIV
- Rapid desaturation during NIV breaks (warning sign of impending failure) 1
Invasive Ventilation Considerations
Discuss with specialist respiratory team before intubation if practicable, as extubation planning requires expertise. 1
Plan extubation at specialist center with NIV and MI-E support post-extubation. 1
Avoid early tracheostomy—this has not been shown to improve outcomes and should only be considered after discussion with DMD-experienced respiratory team. 1
Use lung-protective ventilation: tidal volume 6 mL/kg predicted body weight, respiratory rate 15-25 breaths/minute, I:E ratio 1:1 to 1:2. 2
Cardiac Considerations
Monitor for cardiac complications, as uncorrected hypoventilation can precipitate ventricular arrhythmias in patients with DMD cardiomyopathy. 1
- Correction of hypercapnia/hypoxemia can improve cardiac function if deteriorated due to respiratory failure. 1
- Adjust cardiac medications (beta-blockers) cautiously in setting of respiratory failure. 1
Advance Care Planning
If patient deteriorates despite invasive ventilation with multi-organ failure, reassess goals of care regularly with patient/family input, as this may indicate unsurvivable pathology. 1
- These discussions should ideally have occurred before acute crisis when reduced respiratory reserve was first identified. 1
- Engage palliative care services early for parallel planning. 1
Common Pitfalls to Avoid
- Never administer oxygen without checking for hypercapnia first—this is the most dangerous error in DMD respiratory failure. 1
- Do not use pressure support triggering mode initially—controlled ventilation is more effective in neuromuscular disease. 1
- Do not delay NIV waiting for severe acidosis—start early when hypercapnia detected. 1
- Do not manage on general ward—these patients require HDU/ICU level monitoring. 1
- Do not neglect secretion clearance—this determines NIV success or failure. 1
Post-Acute Management
Continue nocturnal NIV following recovery pending discussion with home mechanical ventilation service, as most patients will require long-term ventilatory support. 1, 3